Genoa Pharmaceuticals
San Diego
About Genoa Pharmaceuticals
Genoa Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of idiopathic pulmonary fibrosis (IPF). It develops GP-101, an aerosol pirfenidone formulation for direct inhalation delivery to the lungs for the treatment of IPF. The company was founded in 2011 and is based in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $64.2M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2017)
- Website: genoapharma.com
- Phone: 619-992-6488
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/genoa-pharmaceuticals-140094 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.